Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.4891
-0.0369 (-7.02%)
At close: May 14, 2025, 4:00 PM
0.5234
+0.0343 (7.01%)
After-hours: May 14, 2025, 7:58 PM EDT

Century Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
4286199303867-
Upgrade
Market Cap Growth
-56.77%-56.77%-34.34%-65.09%--
Upgrade
Enterprise Value
-93-5877-6597-
Upgrade
Last Close Price
0.531.013.325.1315.86-
Upgrade
PS Ratio
6.2813.0388.8858.19--
Upgrade
PB Ratio
0.280.531.081.002.19-
Upgrade
P/TBV Ratio
0.340.681.081.002.19-
Upgrade
P/OCF Ratio
---21.53--
Upgrade
EV/Sales Ratio
--34.33---
Upgrade
Debt / Equity Ratio
0.330.330.260.160.060.29
Upgrade
Asset Turnover
0.020.020.010.01--
Upgrade
Quick Ratio
1.471.479.8110.6114.256.33
Upgrade
Current Ratio
1.501.509.9210.7214.576.51
Upgrade
Return on Equity (ROE)
-73.14%-73.14%-56.07%-37.46%-40.81%-66.45%
Upgrade
Return on Assets (ROA)
-23.67%-23.67%-18.47%-16.75%-21.80%-31.10%
Upgrade
Return on Capital (ROIC)
-37.70%-37.70%-26.75%-20.01%-22.97%-33.63%
Upgrade
Earnings Yield
-296.82%-147.38%-68.80%-43.28%-11.06%-
Upgrade
FCF Yield
-258.65%-128.42%-51.39%-5.47%-15.46%-
Upgrade
Buyback Yield / Dilution
-32.60%-32.60%-2.70%-78.30%-332.95%-10.43%
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q